Global conference and event organiser UBM’s pharmaceuticals portfolio has posted its most successful year to date. The UBM pharma brands – including the largest dedicated pharma exhibition series in the world, CPhI – have reported the launch of CPhI North America, as well as record figures for the eponymous Worldwide edition.
In 2018, UBM will expand its offerings, with the relocation of CPhI Istanbul to Abu Dhabi for CPhI Middle East & Africa, 3-5 September, and bioLIVE, launching 9-11 October.
Last October the world’s largest pharma event, CPhI Worldwide, closed its 28th edition with audited figures indicating a record-breaking attendance of 44,993 and 2,598 exhibitors.
In the last three years, CPhI Worldwide has grown its audience base by 10,000 people, and the company is to launch an independently branded adjacent event in bioLIVE. This new event was created, the company says, after independent research identified a gap in the market for a new global exhibition and content platform that could establish premium-class, global leadership across the entire biomanufacturing value chain.
UBM attributes the increase in attendance at CPhI Worldwide to its commitment to introducing the latest technological advances and matchmaking tools, making the event easier to navigate and furthering opportunities to meet with potential partners. This included 952,152 interactions though its supplier finder system, 9,000 downloads of its mobile app (up 80% year-on-year) and a huge rise in social media engagement.
UBM is optimistic that CPhI North America 2018 will see an increase on the 630 exhibitors that attended the inaugural event.
In Asia, UBM is hosting the largest pharma events in both India and China. CPhI India reported a 20% growth in attendee numbers as UBM launched the second India Pharma Week; featuring 10 events, this week-long platform of bespoke programmes has been a key addition in attracting greater audiences.
CPhI & PMEC China also experienced a 14% growth in overall visits and a 12% growth in overseas visits.
2018 will also see the leading pharma event in the Middle East and Africa move to Abu Dhabi (UAE) from its home of the last four years, Istanbul.
“CPhI Worldwide has yet again achieved another record year with 44,993 attendees and continues to be a bellwether of the entire global industry,” says Andreas Mavrommatis, global marketing director at UBM.
“In 2017, UBM has also expanded its pharma reach into new sectors of the pharmaceutical value chain, as well as geographically, with the successful launch event in North America. Furthermore, we will introduce CPhI Middle East & Africa in September 2018,” Mavrommatis added.
